DE69936774D1 - Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen - Google Patents

Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen

Info

Publication number
DE69936774D1
DE69936774D1 DE69936774T DE69936774T DE69936774D1 DE 69936774 D1 DE69936774 D1 DE 69936774D1 DE 69936774 T DE69936774 T DE 69936774T DE 69936774 T DE69936774 T DE 69936774T DE 69936774 D1 DE69936774 D1 DE 69936774D1
Authority
DE
Germany
Prior art keywords
fish
virus
causes
structural proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936774T
Other languages
English (en)
Inventor
Jonathan Weston
Daniel Todd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of DE69936774D1 publication Critical patent/DE69936774D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69936774T 1998-05-08 1999-05-06 Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen Expired - Lifetime DE69936774D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201461 1998-05-08
PCT/EP1999/003244 WO1999058639A2 (en) 1998-05-08 1999-05-06 Structural proteins of fish pancreatic disease virus and uses thereof

Publications (1)

Publication Number Publication Date
DE69936774D1 true DE69936774D1 (de) 2007-09-20

Family

ID=8233681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936774T Expired - Lifetime DE69936774D1 (de) 1998-05-08 1999-05-06 Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen

Country Status (9)

Country Link
US (4) US6719980B1 (de)
EP (1) EP1075523B1 (de)
JP (1) JP4323720B2 (de)
AT (1) ATE369429T1 (de)
CA (1) CA2327353C (de)
DE (1) DE69936774D1 (de)
DK (1) DK1075523T3 (de)
NO (1) NO327754B1 (de)
WO (1) WO1999058639A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4323720B2 (ja) * 1998-05-08 2009-09-02 インターベツト・インターナシヨナル・ベー・ベー 魚膵臓病ウイルス構造タンパク質およびその使用
CA2457349A1 (en) * 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
FR2887259B1 (fr) * 2005-06-21 2007-09-14 Agronomique Inst Nat Rech CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
WO2009070929A1 (fr) * 2007-12-04 2009-06-11 Schweitzer Co., Ltd. Vaccin sous-unité pour l'aquaculture
NO333242B1 (no) * 2008-02-08 2013-04-15 Pharmaq As Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
US9395356B2 (en) 2009-10-02 2016-07-19 The National Veterinary Institute Piscine reovirus immunogenic compositions
US9139618B2 (en) * 2010-12-29 2015-09-22 Intervet Inc. Salmonid alphavirus protein E2
WO2012130723A1 (en) * 2011-03-25 2012-10-04 Intervet International B.V. Salmonid alphavirus vaccine
EP2895501B1 (de) * 2012-09-17 2017-01-18 Novartis Tiergesundheit AG Salmonid alphavirus und verwendungen davon
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003978D0 (sv) * 1990-12-13 1990-12-13 Henrik Garoff Dna expressionssystem baserade paa ett virus replikon
EP0712926B1 (de) * 1994-10-18 2003-10-08 Akzo Nobel N.V. Virus, welches die Pankreas-Krankheit bei Fischen verursacht
US5843712A (en) * 1996-06-06 1998-12-01 The Trustees Of Columbia University In The City Of New York Sindbis virus expression system for recombinant antibody production
JP4323720B2 (ja) * 1998-05-08 2009-09-02 インターベツト・インターナシヨナル・ベー・ベー 魚膵臓病ウイルス構造タンパク質およびその使用

Also Published As

Publication number Publication date
JP4323720B2 (ja) 2009-09-02
US20080241179A1 (en) 2008-10-02
DK1075523T3 (da) 2007-12-27
US6719980B1 (en) 2004-04-13
EP1075523A2 (de) 2001-02-14
US7341725B2 (en) 2008-03-11
ATE369429T1 (de) 2007-08-15
US20040258707A1 (en) 2004-12-23
CA2327353A1 (en) 1999-11-18
US20110123565A1 (en) 2011-05-26
US8114409B2 (en) 2012-02-14
NO327754B1 (no) 2009-09-14
EP1075523B1 (de) 2007-08-08
WO1999058639A2 (en) 1999-11-18
WO1999058639A3 (en) 1999-12-29
CA2327353C (en) 2010-09-21
JP2002514407A (ja) 2002-05-21
NO20005608D0 (no) 2000-11-07
NO20005608L (no) 2000-11-07

Similar Documents

Publication Publication Date Title
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
MXPA00010722A (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
DK1079811T3 (da) Biologisk nedbrydelige alginatgeler med forlænget frigivelse
WO2002074979A3 (en) Expression profiles and methods of use
ECSP055584A (es) Proceso para la preparación de fibrinógeno
WO2001098317A3 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
ATE330017T1 (de) Kallikrein gen
DE69936774D1 (de) Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
SE9801455D0 (sv) New receptor
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
WO1999004011A3 (en) Hiv-1 group o antigens and uses thereof
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
DK1037916T3 (da) Erythrovirus og dets anvendelser
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
NO20053575L (no) Metallprotease proteiner
ATE305517T1 (de) Neurotrypsin
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
NZ514691A (en) Method to type prion proteins
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2002029023A8 (en) Nicastrin protein

Legal Events

Date Code Title Description
8332 No legal effect for de